Metabolic dysfunction–associated fatty liver disease (MAFLD) has increasingly become a
significant and highly prevalent cause of chronic liver disease, displaying a wide array of risk …

The gut microbiome plays a key role in the health-disease balance in the human body.
Although its composition is unique for each person and tends to remain stable throughout …

Background Cirrhosis is a public health threat associated with high mortality. Alcoholic Liver
Disease (ALD) is the leading cause in Latin America and Metabolic Associated Fatty Liver …

Non-alcoholic steatohepatitis (NASH) is considered the advanced stage of non-alcoholic
fatty liver disease (NAFLD). It is characterized by liver steatosis, inflammation and different …

In 2020, international consensus guidelines recommended the renaming of non-alcoholic
fatty liver disease (NAFLD) to metabolic-associated fatty liver disease (MAFLD), supported …

Metabolic Associated Fatty liver disease (MAFLD) is a global health problem and represents
the most common cause of chronic liver disease in the world. MAFLD spectrum goes from …

Currently, alcoholic liver disease (ALD) is one of the most prevalent chronic liver diseases
worldwide, representing one of the main etiologies of cirrhosis and hepatocellular …

Alcoholic liver disease (ALD) is a clinical-pathologic entity caused by the chronic excessive
consumption of alcohol. The disease includes a broad spectrum of anomalies at the cellular …

The gastrointestinal tract plays an important role in the pathogenesis of COVID-19. The
angiotensin-converting enzyme 2 receptor and the transmembrane protease serine 2 …

Introduction and objectives HCV infection is targeted by the WHO's Global Health Sector
Strategy on Viral Hepatitis to be reduced notably by 2030. However, renovated …